Novavax announced publication of phase 1 data for COVID-19 vaccine candidate in The New England Journal of Medicine
On Sept. 2, 2020, Novavax announced the publication in The New England Journal of Medicine of Phase 1…
Janssen discontinued Pimodivir influenza development program
On Sept. 2, 2020, the Janssen Pharmaceutical Companies of Johnson & Johnson announced that it had made a…
Biotechnology | Diagnostics | HIV | Infectious Disease | Non-Profit Research | Organ Transplant | Therapeutics
UT Southwestern performed first HIV-positive-to-HIV-positive organ transplant in Texas
On Sept. 2, 2020, UT Southwestern (UTSW) announced that it had performed the first HIV-positive-to-HIV-positive organ transplant in…
NIH awarded MicroGEM $409 million to fast-track rapid, no-lab COVID-19 saliva test
On Sept. 2, 2020, MicroGEM announced it had been awarded up to $40.9 million by the National Institutes…
Titers of antibodies against SARS-CoV2 did not decline within four months
On Sept. 1, 2020, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published a study in…
Novavax and Canada reached agreement to acquire Novavax COVID-19 vaccine
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
Moderna confirmed discussions with the MHLW to supply Japan with 40 million doses of mRNA vaccine against COVID-19
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
Laurent Pharmaceuticals received FDA approval to initiate its COVID-19 phase 2 clinical trial in the U.S.
On Aug. 27, 2020, Laurent Pharmaceuticals announced that it had received approval from the U.S. Food and Drug…
Rapid diagnostic detected Lassa and Ebola in real-time
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with…
Momentous milestone as Africa announced eradication of wild Poliovirus
On Aug. 25, 2020, the independent Africa Regional Certification Commission (ARCC) for Polio Eradication officially declared that the…
CytoDyn reached enrollment of 195 patients in its phase 3 trial for COVID-19 patients with severe-to-critical symptoms
On Aug. 25, 2020, CytoDyn announced the Company had reached the requisite number of enrolled patients in its…
Largest global study on hydroxychloroquine safety finds increased cardiovascular risk with azithromycin
On Aug. 24, 2020, the combination of hydroxychloroquine and azithromycin has been linked to significant cardiovascular risks, including…
University of Oxford study described which cancer patients are more vulnerable to COVID-19
On Aug. 24, 2020, a published study led by the Universities of Oxford and Birmingham found that, compared…
Novavax initiated phase 2 portion of phase 1/2 clinical trial of COVID-19 vaccine
On Aug. 24, 2020, Novavax announced that the first volunteers were enrolled in the Phase 2 portion of…
Mayo Clinic discontinued enrollment in Expanded Access Program for convalescent plasma with FDA Emergency Use Authorization
On Aug. 23, 2020, the Mayo Clinic announced that with the FDA Emergency Use Authorization of convalescent plasma,…
172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility
On Aug. 23, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2
On Aug. 19, 2020, Sorrento announced that it had filed an investigational new drug application (IND) for COVI-GUARD…
UT Southwestern announced open enrollment for at-home COLCORONA clinical trial
On Aug. 19, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced what is expected…
Novavax initiated efficacy trial of COVID-19 vaccine in South Africa
On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…
XBiotech announced COVID-19 candidate therapy
On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…
Vaccine refusal and measles outbreaks increased in the U.S.
On Aug. 14, 2020, in the U.S., despite high rates of coverage (>90%) at the national level for…
Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate
On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…
Biotechnology | HIV | Infectious Disease | Medicine | Therapeutics | Vaccine | WHO
China National Medical Products Administration approved Truvada for HIV pre-exposure prophylaxis
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
Moderna announced supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19
On Aug. 11, 2020, Moderna announced that the U.S. government had secured 100 million doses of mRNA-1273. The…
Scientists revealed structural details of spike protein used in leading COVID-19 vaccine
On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…
Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in Japan
On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…
Novavax signed COVID-19 vaccine supply deal with India’s Serum Institute
On Aug. 6, 2020, Novavax announced it had entered a supply and license agreement with the Serum Institute…
NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
Novavax announced positive phase 1 data for its COVID-19 vaccine candidate
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…